Clinical Trial Update: Pilot Study to Evaluate the Safety and Efficacy of Treatment With ORA102 Combined With Avastin (Bevacizumab) Versus Avastin Alone, in Patients With Neovascular Age Related Macular Degeneration (AMD) [Phase 1, Phase 2]

View source ↗

Summary

A pilot Phase 1/Phase 2 trial evaluating the safety and efficacy of ORA102 in combination with Avastin versus Avastin alone for neovascular age-related macular …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neovascular Age-related Macular Degeneration

Drugs mentioned

• Avastin (bevacizumab)
• ORA102

Snippet

Sponsor: Ora Bio Ltd. | Conditions: Macular Degeneration | Phase 1, Phase 2 | Status: UNKNOWN